UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ACE and LRPAP1 Insertion-Deletion Polymorphisms in a Northern Ivory Coast Population

Human biology, 2007-12, Vol.79 (6), p.699-706

2007

Volltextzugriff (PDF)

AEE788: A dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (14), p.4931-4941

2004

Volltextzugriff (PDF)

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity

International journal of cancer, 1989-05, Vol.43 (5), p.851-856

1989

Volltextzugriff (PDF)

Tyrosine kinase inhibitors: From rational design to clinical trials

Medicinal research reviews, 2001-11, Vol.21 (6), p.499-512

2001

Volltextzugriff (PDF)

Erythrocyte polymorphisms in five ethnic groups of Northern Côte d'Ivoire

International journal of immunogenetics, 2009-06, Vol.36 (3), p.189-191

2009

Volltextzugriff (PDF)

Potent Antagonists of the SH2 Domain of Grb2: Optimization of the X+1 Position of 3-Amino-Z-Tyr(PO3H2)-X+1-Asn-NH2

Journal of medicinal chemistry, 1998-05, Vol.41 (11), p.1741-1744

1998

Volltextzugriff (PDF)

COL1A2 gene deletion polymorphism in an Italian and an Ivorian populations

Genetika, 2009-07, Vol.45 (7), p.977

2009

Volltextzugriff (PDF)

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs

Pharmacology & therapeutics (Oxford), 2002-02, Vol.93 (2), p.79-98

2002

Volltextzugriff (PDF)

Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode

Nature structural biology, 1996-07, Vol.3 (7), p.586-589

1996

Volltextzugriff (PDF)

COL1A2 gene deletion polymorphism in an Italian and an Ivorian populations

Russian journal of genetics, 2009-07, Vol.45 (7), p.857-860

2009

Volltextzugriff (PDF)

In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors

Antimicrobial Agents and Chemotherapy, 1996-06, Vol.40 (6), p.1442-1447

1996

Volltextzugriff (PDF)

Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison

Genes & cancer, 2010-10, Vol.1 (10), p.1021-1032

2010

Volltextzugriff (PDF)

The Total Synthesis and Biological Assessment of trans-Epothilone A

Helvetica chimica acta, 2002-11, Vol.85 (11), p.4086-4110

2002

Volltextzugriff (PDF)

Selective GRB2 SH2 inhibitors as anti‐Ras therapy

International journal of cancer, 1999-10, Vol.83 (2), p.235-241

1999

Volltextzugriff (PDF)

Synthesis and biological evaluation of highly potent analogues of epothilones B and D

Bioorganic & medicinal chemistry letters, 2000-12, Vol.10 (24), p.2765-2768

2000

Volltextzugriff (PDF)

Structure-Based Design and Synthesis of High Affinity Tripeptide Ligands of the Grb2-SH2 Domain

Journal of medicinal chemistry, 1998-08, Vol.41 (18), p.3442-3449

1998

Volltextzugriff (PDF)

Author errata

International journal of cancer, 1999-05, Vol.81 (4), p.669-669

1999

Volltextzugriff (PDF)

Effect of Potent and Selective Inhibitors of the Grb2 SH2 Domain on Cell Motility

The Journal of biological chemistry, 1999-08, Vol.274 (33), p.23311-23315

1999

Volltextzugriff (PDF)

Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands

Journal of molecular biology, 1998-06, Vol.279 (4), p.1013-1022

1998

Volltextzugriff (PDF)

Discovery of 3-Aminobenzyloxycarbonyl as an N-Terminal Group Conferring High Affinity to the Minimal Phosphopeptide Sequence Recognized by the Grb2-SH2 Domain

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3551-3556

1997

Volltextzugriff (PDF)

Highly potent inhibitors of the Grb2-SH2 domain

Bioorganic & medicinal chemistry letters, 1999-01, Vol.9 (2), p.221-226

1999

Volltextzugriff (PDF)

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

Journal of computer-aided molecular design, 1995-12, Vol.9 (6), p.465-472

1995

Volltextzugriff (PDF)

Epothilones and Their Analogs – Potential New Weapons in the Fight Against Cancer

Chimia, 2000-01, Vol.54 (11), p.612

2000

Volltextzugriff (PDF)

Structure-based design of a non-peptidic antagonist of the SH2 domain of GRB2

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (14), p.1973-1978

1999

Volltextzugriff (PDF)

Natural Product-Based Drug Discovery – Epothilones as Lead Structures for the Discovery of New Anticancer Agents

Chimia, 2004-10, Vol.58 (10), p.686

2004

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(61)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(35)
Biological And Medical Sciences
(21)
Humans
(21)
Physical Sciences
(21)
Chemistry
(20)
Medical Sciences
(20)
Pharmacology & Pharmacy
(17)
Pharmacology. Drug Treatments
(17)
Antineoplastic Agents
(15)
Chemistry, Medicinal
(14)
General Aspects
(14)
Adaptor Proteins, Signal Transducing
(13)
Animals
(13)
Grb2 Adaptor Protein
(13)
Chemistry, Organic
(10)
Src Homology Domains
(10)
Female
(9)
Structure-Activity Relationship
(9)
Models, Molecular
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ACE and LRPAP1 Insertion-Deletion Polymorphisms in a Northern Ivory Coast Population

AEE788: A dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity

Tyrosine kinase inhibitors: From rational design to clinical trials

Erythrocyte polymorphisms in five ethnic groups of Northern Côte d'Ivoire

Potent Antagonists of the SH2 Domain of Grb2: Optimization of the X+1 Position of 3-Amino-Z-Tyr(PO3H2)-X+1-Asn-NH2

COL1A2 gene deletion polymorphism in an Italian and an Ivorian populations

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs

Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode

COL1A2 gene deletion polymorphism in an Italian and an Ivorian populations

In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors

Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison

The Total Synthesis and Biological Assessment of trans-Epothilone A

Selective GRB2 SH2 inhibitors as anti‐Ras therapy

Synthesis and biological evaluation of highly potent analogues of epothilones B and D

Structure-Based Design and Synthesis of High Affinity Tripeptide Ligands of the Grb2-SH2 Domain

Author errata

Effect of Potent and Selective Inhibitors of the Grb2 SH2 Domain on Cell Motility

Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands

Discovery of 3-Aminobenzyloxycarbonyl as an N-Terminal Group Conferring High Affinity to the Minimal Phosphopeptide Sequence Recognized by the Grb2-SH2 Domain

Highly potent inhibitors of the Grb2-SH2 domain

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

Epothilones and Their Analogs – Potential New Weapons in the Fight Against Cancer

Structure-based design of a non-peptidic antagonist of the SH2 domain of GRB2

Natural Product-Based Drug Discovery – Epothilones as Lead Structures for the Discovery of New Anticancer Agents

Suchergebnisse filtern